// App-Quantinova.ai

9080 : A phase I trial of certolizumab plus chemotherapy in patients with stage IV lung adenocarcinomas.

Researchers

Presenter

  • Paul K. Paik

Principal Investigators

  • Juliana Eng

  • Leslie Perez

  • Erika Ritter

  • Kenneth K. Ng

  • John Joseph Fiore

  • Phillip Wong

  • Charles M. Rudin

  • Joan Massague

  • Mark G. Kris

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Memorial Sloan Kettering Cancer Center, Rockville Centre, NY

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • Certolizumab pegol

  • Pemetrexed

  • Cisplatin

Outcome

  • N/A

Study Design

  • Pharmacodynamics

Phase

  • I

Study Id's

  • NCT02120807

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved